https://european-biotechnology.net/wp-content/uploads/2024/10/EFSA-Gourmey-1030x824-1.png
824
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-10-01 10:11:542024-10-01 14:02:02EFSA updates guidelines on cultured proteins and Novel Food
https://european-biotechnology.net/wp-content/uploads/2024/09/LevinJM_Headshot_FINAL_20161028-1030x677-1.jpg
677
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-09-30 04:00:172024-09-30 04:00:17Long version of The BIOSECURE Act: The West’s Wake-Up Call to China’s Biotech Dominance
https://european-biotechnology.net/wp-content/uploads/2024/09/Asabys-management-team_©-Asabys-Partners-e1727419179308-1030x580-1.jpg
580
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-09-27 06:40:262024-09-27 06:40:26Asabys Partners close €180m Sabadell Asabys II Fund
https://european-biotechnology.net/wp-content/uploads/2024/09/Alessio-Cantore-e1727256487625.jpg
242
430
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-09-25 09:33:552024-09-25 09:33:55Genespire raises US$52m in Series B round
https://european-biotechnology.net/wp-content/uploads/2024/09/virus-bacteria-pills-1030x579-1.jpg
579
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-09-24 04:06:012024-09-24 04:06:01AMR Accelerator urges long-term funding
https://european-biotechnology.net/wp-content/uploads/2024/09/Vicebio_Respiratory_Syncytial_Virus_RSV_EM_PHIL_2175_lores-e1727100671948-1030x580-1.jpg
580
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-09-23 14:12:002024-09-23 14:12:00Vicebio Ltd cashes in US$100m in Series B financing
https://european-biotechnology.net/wp-content/uploads/2024/09/STEP-2-1-5-e1726737997871.jpg
563
1000
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-09-19 09:27:312024-09-19 09:27:31French Brenus AS closes US$25m financing
https://european-biotechnology.net/wp-content/uploads/2024/09/324EB_von-der-Leyen_tg-1030x687-1.webp
687
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-09-18 09:20:452024-09-26 16:32:01Von der Leyen names new EU Commissioners
https://european-biotechnology.net/wp-content/uploads/2024/09/ImmunOS.png
404
748
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-09-17 13:17:552024-09-17 13:17:55ImmunOs Therapeutics AG raises US$11m in Series C financing
https://european-biotechnology.net/wp-content/uploads/2024/09/Richter-Biologics-red-tape-e1726401635512-1030x580-1.png
580
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-09-15 12:10:432024-09-15 12:10:43Richter-Helm Biologics triples production capacity
Scroll to top
